Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by gebremeskelon Jun 22, 2019 12:32am

87 Views

Post# 29852031

RE:RE:So Much Speculation

Good luck getting anything out of investor relations that is not already in a news release. Theralase has learned it's lesson - loose lips sink ships.

hydrocarbss wrote: B$Man, have you emailed investor relations? They would speak for Theralase.

This board, read by about 80 to 100 bloggers can do nothing about the 'darkness'.

Bullboard Posts

Changing Europe’s dependency on HREE from China